Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St Jude gets US nod to add V-V (ventricle to ventricle) timing in CRT-Ds (cardiac resynchronisation therapy devices):

This article was originally published in Clinica

Executive Summary

The US FDA has given St Jude Medical approval to add V-V (ventricle to ventricle) timing to new models of its Epic HF and Atlas+ HF family of cardiac resynchronisation therapy devices (CRT-Ds). V-V timing refers to the delay between contraction of the left and right ventricles, compared with simultaneous pulses to both ventricles. St Jude's V-V timing allows physicians to adjust the delay between ventricular outputs, and choose which chamber is paced first. Patients who do not respond to simultaneous biventricular pacing systems may benefit from the sequential timing offered by V-V programmability, said the St Paul, Minnesota firm, which believes it is the first CRT-D supplier in the US to offer this expanded programmability.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060387

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel